A U.S. district court dismisses thousands of lawsuits involving Zantac, which spells relief for GSK (GSK), Sanofi (SNY) and Pfizer (PFE). Pfizer and AbbVie (ABBV) announce new research collaborations.
If you're looking to add more dividend stocks to your portfolio this month, it's important to focus on companies that not only regularly increase their payout to investors but have a long track record of maintaining their dividends even in difficult environments. Here are two such top dividend stocks to consider adding to your portfolio ASAP. AbbVie (NYSE: ABBV) originated as a spin-off of Abbott Laboratories nearly a decade ago, and in doing so, inherited its predecessor's dividend history.
AbbVie (ABBV) closed at $165.99 in the latest trading session, marking a +0.36% move from the prior day.